Cargando…

Prognostic utility of late gadolinium enhancement on cardiac magnetic resonance in cardiac amyloidosis: a meta-analysis

Detalles Bibliográficos
Autores principales:	Raina, Sameer, Lensing, Shelly, Nairooz, Ramez, Pothineni, Naga Venkata K, Hakeem, Abdul, Bhatti, Sabha, Pandey, Tarun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032315/ http://dx.doi.org/10.1186/1532-429X-18-S1-P115

Ejemplares similares

Clinical characteristics and predictors of mortality in patients with normal wall thickness cardiac amyloidosis
por: Bhatti, Sabha, et al.
Publicado: (2016)

Late gadolinium enhancement (LGE) on Cardiac MR is a powerful predictor of death and “hard” events in patients with hypertrophic cardiomyopathy (HCM)
por: Bhatti, Sabha, et al.
Publicado: (2012)

Extrapolating echocardiographic determinants of elevated Left Atrial Pressure (LAP) to Cardiac Magnetic Resonance Imaging (CMR) to determine the best CMR correlate of elevated LAP
por: Rao Edupuganti, Mohan Mallikarjuna, et al.
Publicado: (2016)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

Determination of strain pattern in patients with cardiac amyloidosis secondary to Multiple myeloma: a feature tracking study
por: Bhatti, Sabha, et al.
Publicado: (2016)

Comparison of late gadolinium enhancement patterns in different forms of cardiac amyloidosis
por: Kammerer, Rebekka, et al.
Publicado: (2013)

Role of cardiovascular magnetic resonance in suspected cardiac amyloidosis: late gadolinium enhancement pattern as mortality predictor
por: Baroni, M., et al.
Publicado: (2017)

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
por: Dungu, Jason, et al.
Publicado: (2012)

3.0T cardiac magnetic resonance quantification of native T1 and myocardial extracellular volume for the diagnosis of late gadolinium enhancement-negative cardiac amyloidosis
por: Liu, Yumeng, et al.
Publicado: (2022)

Evaluation of myocardial strain in patients with myocardial amyloidosis using feature-tracking technique
por: Pandey, Tarun, et al.
Publicado: (2016)

Diagnosis of Cardiac Amyloidosis Using a Radiomics Approach Applied to Late Gadolinium-Enhanced Cardiac Magnetic Resonance Images: A Retrospective, Multicohort, Diagnostic Study
por: Zhou, Xi Yang, et al.
Publicado: (2022)

Navigating Challenging Left Ventricular Lead Placements for Cardiac Resynchronization Therapy
por: Pothineni, Naga Venkata K., et al.
Publicado: (2020)

Cardiac drug therapy—considerations in the elderly
por: Ayan, Mohamed, et al.
Publicado: (2016)

Comparison of regional and global cardiac MRI diastolic strain rates with echo grading of diastolic dysfunction
por: Pandey, Tarun, et al.
Publicado: (2016)

Multimodality Imaging for Diagnosing Transthyretin Cardiac Amyloidosis
por: Palot Manzil, Fathima Fijula, et al.
Publicado: (2023)

Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance
por: Leyva, Francisco, et al.
Publicado: (2011)

Magnetic resonance imaging of cardiac sarcoidosis: an evaluation of the cardiac segments and layers that exhibit late gadolinium enhancement
por: Komada, Tomohiro, et al.
Publicado: (2016)

Severe Left Ventricular Hypertrophy, Small Pericardial Effusion, and Diffuse Late Gadolinium Enhancement by Cardiac Magnetic Resonance Suspecting Cardiac Amyloidosis: Endomyocardial Biopsy Reveals an Unexpected Diagnosis
por: Hofmann, Nina P., et al.
Publicado: (2016)

Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up
por: Migrino, Raymond Q, et al.
Publicado: (2009)

Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics
por: Williams, Lynne K., et al.
Publicado: (2017)

Prognostic value of adenosine stress perfusion cardiac magnetic resonance with late gadolinium enhancement
por: Bertaso, Angela G, et al.
Publicado: (2011)

Cardiac phase-resolved late gadolinium enhancement imaging
por: Weingärtner, Sebastian, et al.
Publicado: (2022)

Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy
por: Sano, Makoto, et al.
Publicado: (2016)

Unique pattern of late gadolinium enhancement on cardiac magnetic resonance imaging in Duchenne muscular dystrophy
por: Ganigara, Madhusudan, et al.
Publicado: (2016)

Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis
por: Sano, Makoto, et al.
Publicado: (2014)

Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy
por: Schelbert, Erik B., et al.
Publicado: (2017)

Detection of late radiation damage on left atrial fibrosis using cardiac late gadolinium enhancement magnetic resonance imaging
por: Huang, Y. Jessica, et al.
Publicado: (2016)

Can late gadolinium enhancement on cardiovascular magnetic resonance describe cardiac involvement in patients with systemic sarcoidosis and/or suspect of cardiac involvement of sarcoidosis with cardiac symptoms?
por: Kasai, Yufuko, et al.
Publicado: (2011)

Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging
por: Hees, Tilman A, et al.
Publicado: (2013)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013)

Prognostic impact of late gadolinium enhancement cardiac magnetic resonance in the risk stratification of heart transplant patients
por: Pedrotti, Patrizia, et al.
Publicado: (2016)

Early markers of heart damage in systemic sclerosis: role of cardiac magnetic resonance with late gadolinium enhancement
por: Lario, Chiara Valentina, et al.
Publicado: (2016)

Prognostic value of late gadolinium enhancement cardiac magnetic resonance in hypertrophic cardiomyopathy: a meta-analysis
por: Weng, Zhen, et al.
Publicado: (2016)

Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
por: Doesch, Christina, et al.
Publicado: (2017)

Quantitative Assessment of Late Gadolinium Enhancement and Edema at Cardiac Magnetic Resonance in Low-Risk Myocarditis Patients
por: Monti, Caterina Beatrice, et al.
Publicado: (2022)

Value of late gadolinium enhancement by magnetic resonance in patients with cardiac sarcoidosis: characteristic findings and clinical utility
por: Watanabe, Eri, et al.
Publicado: (2009)

Combined stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance provides robust prognostic information to cardiac events
por: Coelho-Filho, Otavio, et al.
Publicado: (2011)

Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis
por: Maceira, Alicia M, et al.
Publicado: (2008)

The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis
por: Lin, Lu, et al.
Publicado: (2018)

Atypical Distribution of Late Gadolinium Enhancement of the Left Ventricle on Cardiac Magnetic Resonance in Classical Anderson-Fabry Disease
por: Kasuya, Shusuke, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p1nl7rg66h19ug1arkrdqmkpk1